ImmunoBiome

Last Round
Series BDec 2019
Rounds
2

About

Microbiome-based anticancer and anti-inflammatory drug development

Summary

Its most recent funding was a Series B round in Dec 2019. Investors include SBI Investment Korea, Union Ventures and AJU IB Investment.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundDec 2019

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors